Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

624

HTML

4721

Figures (1-4)

335

Tables (1-3)

256

Sum=5936

Mar 14, 2008 (publication date) through Feb 24, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 14, 2008; 14(10): 1491-1497
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1491

Table 2 IC₅₀ values of chemotherapeutic drugs in human cancer cells

Data are shown as mean ± SD from three separate experiments.

Citation: Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol 2008; 14(10): 1491-1497
URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1491.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1491